Phase I and pharmacokinetic trial of the antitemolerase agent KML001 (KML) and cisplatin (CDDP) in advanced solid tumors.
Martin J. Edelman
Consultant or Advisory Role - Kominox
Honoraria - Kominox
Josephine Louella Feliciano
No relevant relationships to disclose
Miroslav Styblo
No relevant relationships to disclose
Tao Liu
No relevant relationships to disclose
Rena G. Lapidus
No relevant relationships to disclose
Jesse Saunders
No relevant relationships to disclose
Joga Gobburu
No relevant relationships to disclose